turmeric
6 interactions related to turmeric
curcumin + boswellia
Curcumin and boswellia act on complementary anti-inflammatory pathways (NF-kB/prostaglandins and 5-LOX/leukotrienes), and a randomized placebo-controlled trial found the combination eased knee osteoarthritis symptoms more than curcumin alone.
curcumin + ginger
Curcumin and ginger share overlapping anti-inflammatory mechanisms (COX-2 and NF-kB inhibition), with ginger adding 5-LOX blockade that curcumin lacks. The combination is favourable and complementary, with both contributing mild antiplatelet potential worth checking before combining with blood thinners.
warfarin + turmeric
Curcumin, the main active in turmeric, has antiplatelet activity that can add to warfarin's effect and raise bleeding risk. New Zealand's medicines regulator, Medsafe, issued an alert in 2018 after a patient stable on warfarin had their INR climb to a dangerously high level within weeks of starting a turmeric/curcumin product. A possible effect on the enzyme that clears warfarin has been seen only in animal and laboratory studies, not in people.
curcumin + fat
Curcumin is a lipophilic molecule with very low water solubility, and dietary fat improves its dissolution and incorporation into bile-acid micelles for intestinal absorption. Taking curcumin or turmeric with a fat-containing meal, and using lipid-based formulations, raises its plasma exposure compared with intake on an empty stomach.
turmeric + black pepper
Piperine, the active alkaloid in black pepper, slows the gut and liver enzymes that normally inactivate curcumin (the main bioactive in turmeric). Taking the two together substantially increases how much curcumin reaches the bloodstream, which is why piperine is one of the most common absorption enhancers in turmeric supplements. The same enzyme effect can also raise levels of some prescription drugs, so concentrated daily supplement doses warrant a pharmacist check for people on chronic medications.
turmeric tea + warfarin
Curcumin, the main active compound in turmeric, has antiplatelet and anticoagulant activity in laboratory studies and may inhibit the liver enzymes that clear warfarin. Regulatory case reports describe stable warfarin patients whose INR rose into a dangerous, emergency range within weeks of starting a turmeric product. The published evidence is limited to a small number of case reports, but the bleeding signal is consistent enough to warrant caution.
